Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. officials describe recent developments
Published in Law and Health Weekly, July 28th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Teva Pharmaceutical Industries Ltd..
Report 1: Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced that the U.S. District Court for the District of New Jersey has issued a decision in its litigation over the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Pfizer's Celebrex(R) (Celecoxib) Capsules, 100 mg, 200 mg, and 400 mg, holding the three patents at issue valid and enforceable. Teva plans to appeal this decision.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Allsup Inc.
Allsup Examines Impact of Social Security Taxes on Disabled and their Families - American Council of Life Insurers
ACLI Annual Conference Will Bring Life Insurance Industry Leaders to Washington, D.C. This Fall - American Life League
Law Evicts Planned Parenthood From Schools; a Noteworthy Victory for Parents in Missouri - Amistaff Healthcare Technology, Inc.
Amistaff Healthcare Technology, Inc. Announces a New Exam Validation Process to Improve the Quality of Patient Care - Antares Pharma
Antares Pharma Announces Closing of $16 Million Private Placement - AuthorHouse
'Murder Without Death': Small-Town Doctor Narrates His Fight Against Corruption - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
